Preparing a marketing authorization application—whether a New Drug Application (NDA) for small molecules or a Biologics License Application (BLA) for biologics—represents the most herculean effort a biotechnology organization can undertake. For leaders—CEOs, CSOs, and CTOs—of growing biotechs, this moment is not just an administrative step, but the culmination of years of rigorous research, massive investment, and constant technical challenges. At 3Biotech, we view this proce